PRESS RELEASE published on 04/18/2023 at 08:00, 3 years 5 months ago Biophytis Announces 2022 Financial Results and 2023 Perspectives
PRESS RELEASE published on 04/17/2023 at 23:00, 3 years 5 months ago Biophytis: Results of the Combined General Meeting on April 17, 2023
PRESS RELEASE published on 04/17/2023 at 23:00, 3 years 5 months ago Biophytis: Résultats de l’Assemblée Générale Mixte du 17 avril 2023
PRESS RELEASE published on 03/30/2023 at 23:00, 3 years 5 months ago Biophytis: L’Assemblée Générale mixte se tiendra en seconde convocation le 17 avril 2023
PRESS RELEASE published on 03/30/2023 at 23:00, 3 years 5 months ago Biophytis: The Combined General Meeting will be held on second call on April 17, 2023
PRESS RELEASE published on 03/27/2023 at 08:00, 3 years 5 months ago Biophytis a présenté Sarconeos (BIO101) comme potentiel candidat médicament dans le traitement du COVID long après hospitalisation, lors du 13ème Congrès annuel International sur la Fragilité et la Sa
PRESS RELEASE published on 03/27/2023 at 08:00, 3 years 5 months ago Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea
PRESS RELEASE published on 03/17/2023 at 08:00, 3 years 6 months ago Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
PRESS RELEASE published on 03/17/2023 at 08:00, 3 years 6 months ago Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR')
PRESS RELEASE published on 03/09/2023 at 08:00, 3 years 6 months ago Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference
Published on 09/23/2026 at 22:00, 9 hours 32 minutes ago Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 13 hours 7 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 15 hours 50 minutes ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 17 hours 1 minute ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 17 hours 2 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/24/2026 at 07:15, 17 minutes ago EQS-Adhoc: Shelly Group SE enters into Investment Agreement with Schneider Electric SE
Published on 09/24/2026 at 07:00, 32 minutes ago flatexDEGIRO sets new cost benchmark for Germany’s Retirement Savings Account (Altersvorsorgedepot)
Published on 09/24/2026 at 07:00, 32 minutes ago Europe’s small & mid caps: Opportunities remain intact in a new investment era
Published on 09/24/2026 at 07:00, 32 minutes ago bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies
Published on 09/24/2026 at 07:00, 32 minutes ago bioMérieux lance SPINCHIP® hs-cTnl, une innovation majeure pour le dosage hypersensible de la troponine I cardiaque et l’accélération de la prise en charge des urgences cardiaques
Published on 09/23/2026 at 19:46, 11 hours 45 minutes ago SFPI GROUP: publication des résultats semestriels 2026
Published on 09/23/2026 at 19:14, 12 hours 18 minutes ago Robust performance from Investments and continued execution of the strategy
